These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 25970480)

  • 1. Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Röhrig UF; Majjigapu SR; Vogel P; Zoete V; Michielin O
    J Med Chem; 2015 Dec; 58(24):9421-37. PubMed ID: 25970480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening.
    Sari S; Tomek P; Leung E; Reynisson J
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a Novel Scaffold as an Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Based on the Pyrrolopiperazinone Alkaloid, Longamide B.
    Shiokawa Z; Kashiwabara E; Yoshidome D; Fukase K; Inuki S; Fujimoto Y
    ChemMedChem; 2016 Dec; 11(24):2682-2689. PubMed ID: 27863031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and Plasticity of Indoleamine 2,3-Dioxygenase 1 (IDO1).
    Röhrig UF; Michielin O; Zoete V
    J Med Chem; 2021 Dec; 64(24):17690-17705. PubMed ID: 34907770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening.
    Guo W; Yao S; Sun P; Yang TB; Tang CP; Zheng MY; Ye Y; Meng LH
    Acta Pharmacol Sin; 2020 Mar; 41(3):423-431. PubMed ID: 31197246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of potent IDO1 inhibitors derived from tryptophan using scaffold-hopping and structure-based design approaches.
    Zou Y; Wang Y; Wang F; Luo M; Li Y; Liu W; Huang Z; Zhang Y; Guo W; Xu Q; Lai Y
    Eur J Med Chem; 2017 Sep; 138():199-211. PubMed ID: 28667875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2,3-dioxygenase 1 (IDO1) inhibition properties.
    Qian S; He T; Wang W; He Y; Zhang M; Yang L; Li G; Wang Z
    Bioorg Med Chem; 2016 Dec; 24(23):6194-6205. PubMed ID: 27769672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
    Fung SP; Wang H; Tomek P; Squire CJ; Flanagan JU; Palmer BD; Bridewell DJ; Tijono SM; Jamie JF; Ching LM
    Bioorg Med Chem; 2013 Dec; 21(24):7595-603. PubMed ID: 24262887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of IDO1 and DNA dual targeting antitumor agents.
    Fang K; Wu S; Dong G; Wu Y; Chen S; Liu J; Wang W; Sheng C
    Org Biomol Chem; 2017 Dec; 15(47):9992-9995. PubMed ID: 29177308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-L-methyltryptophan is a more effective inhibitor of vertebrate IDO2 enzymes than 1-D-methyltryptophan.
    Yuasa HJ; Ball HJ; Austin CJ; Hunt NH
    Comp Biochem Physiol B Biochem Mol Biol; 2010 Sep; 157(1):10-5. PubMed ID: 20399882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase.
    Li Y; Zhang S; Wang R; Cui M; Liu W; Yang Q; Kuang C
    Bioorg Med Chem Lett; 2020 Jun; 30(11):127159. PubMed ID: 32247733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy.
    Weng T; Qiu X; Wang J; Li Z; Bian J
    Eur J Med Chem; 2018 Jan; 143():656-669. PubMed ID: 29220788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies.
    Griglio A; Torre E; Serafini M; Bianchi A; Schmid R; Coda Zabetta G; Massarotti A; Sorba G; Pirali T; Fallarini S
    Bioorg Med Chem Lett; 2018 Feb; 28(4):651-657. PubMed ID: 29398544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO).
    Zhang S; Guo L; Yang D; Xing Z; Li W; Kuang C; Yang Q
    Bioorg Chem; 2020 Nov; 104():104348. PubMed ID: 33142415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel discovery of selective and dual inhibitors of tryptophan dioxygenases IDO1 and TDO2 with a newly-modified enzymatic assay.
    Capochiani de Iudicibus R; Tomek P; Palmer BD; Tijono SM; Flanagan JU; Ching LM
    Bioorg Med Chem; 2021 Jun; 39():116160. PubMed ID: 33901770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes.
    Seegers N; van Doornmalen AM; Uitdehaag JC; de Man J; Buijsman RC; Zaman GJ
    J Biomol Screen; 2014 Oct; 19(9):1266-74. PubMed ID: 24870017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel High Throughput Virtual Screening Protocol to Discover New Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Xu H; Song Y; Yang Q
    Chem Pharm Bull (Tokyo); 2017; 65(8):714-717. PubMed ID: 28768924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.
    Gao D; Li Y
    Bioorg Med Chem; 2017 Jul; 25(14):3780-3791. PubMed ID: 28526475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.